Trials / Completed
CompletedNCT03774381
Effect of Bifidobacterium Breve B-3 on Body Fat in Obese Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Pusan National University Yangsan Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Comparison of a randomized, double-blind, and control-group study for the effect of oral ingestion of Bifidobacterium breve B-3 on body fat reduction in obese adults
Detailed description
Our aim is to investigate the effect of oral ingestion of Bifidobacterium breve B-3 on body fat reduction in adults by a randomized, double-blind, and control-group study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Bifidobacterium breve B-3 | 160 mg of Bifidobacterium breve B-3 is orally administered per day for 12 weeks. |
| DIETARY_SUPPLEMENT | Control group | 160 mg of placebo is orally administered per day for 12 weeks. |
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2019-07-31
- Completion
- 2019-08-01
- First posted
- 2018-12-13
- Last updated
- 2019-09-11
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03774381. Inclusion in this directory is not an endorsement.